The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

Large pharma companies at World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

13 large pharma companies are at World Vaccine Congress 2027 — 14 presentations on the program and 3 with a booth in the exhibit hall. Most represented: Sanofi (4 on the program), Pfizer (4 on the program), Eli Lilly (3 on the program). 5 of them have their own page in this guide. As of Oct 8, 2026.

All 222 organizations at World Vaccine Congress 2027 →

Showing 1–13 of 13 organizations

Organization	World Vaccine Congress 2027 Attendance
Sanofi Paris, France
sanofi.com Large pharmaBronze sponsor Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs.	Booth Exhibiting (no floor booth listed) Chair Wed Mar 10 09:00 Chair’s opening remarks Influenza & Respiratory Diseases Track Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. with Omniose, Vaxcyte, Eli Lilly Talk Wed Mar 10 15:40 Sanofi Respiratory Vaccine Pipeline Updates Influenza & Respiratory Diseases Track
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases.	Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. with Africa CDC Clinical & preclinical developmentSupply, safety & access Talk Wed Mar 10 15:10 Pfizer Respiratory Vaccine Pipeline Updates Influenza & Respiratory Diseases Track Talk Wed Mar 10 16:40 Strategies for large scale vaccinations for the world – multidose vial and CMC challenges Bioprocessing & Manufacturing Track
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company whose medicines span diabetes, obesity, oncology, immunology and neuroscience, with antibody research against infectious diseases.	Talk Mon Mar 8 10:00 Antibodies for Infectious Diseases Workshop Research on antibody medicines that treat or prevent infectious diseases. with AstraZeneca, ModeX Therapeutics, GigaGen Panel Wed Mar 10 09:10 Panel: Pharma Ready: What It Really Takes to Seal the Deal What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation. with Omniose, Vaxcyte, Sanofi
Moderna Cambridge, MA
modernatx.com Large pharma mRNA medicines company with marketed vaccines against COVID-19 and RSV, and mRNA candidates for influenza, other infections and cancer.	Chair Wed Mar 10 09:00 Chair’s opening remarks Vaccine Safety Track
AstraZeneca Cambridge, United Kingdom
astrazeneca.com Large pharma Global pharmaceutical company whose vaccines and immune therapies unit develops antibodies and vaccines against respiratory and other infections.	Talk Mon Mar 8 10:00 Antibodies for Infectious Diseases Workshop Research on antibody medicines that treat or prevent infectious diseases. with ModeX Therapeutics, Eli Lilly, GigaGen
Merck Rahway, NJ
merck.com Large pharma Global pharmaceutical company (MSD outside the US and Canada) making vaccines against pneumococcal disease, HPV, measles and other infections.	Chair Wed Mar 10 09:00 Chair’s opening remarks Vaccine Supply & Logistics Track
Elanco
elanco.com Large pharma Animal health company making medicines and vaccines for farm animals and pets.	Talk Wed Mar 10 09:10 Veterinary & One Health Track: sessions to be announced with BiomEdit, Dalan Animal Health, Zoetis +4 more
GV GSK Vaccines Institute for Global Health Siena, Italy
Large pharma GSK research institute developing vaccines against diseases of low- and middle-income countries, such as shigellosis and invasive salmonella.	Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. with Omniose, AMR Strategic Coalition, Gates Foundation +6 more
Zoetis Parsippany, NJ
zoetis.com Large pharma Animal health company making medicines, vaccines and diagnostics for pets and livestock.	Talk Wed Mar 10 09:10 Veterinary & One Health Track: sessions to be announced with BiomEdit, Dalan Animal Health, The World Bank +4 more
BioNTech Mainz, Germany
biontech.com Large pharma Develops mRNA vaccines and immunotherapies for infectious diseases and cancer, including the marketed COVID-19 vaccine Comirnaty.
GSK London, United Kingdom
gsk.com Large pharma Global pharmaceutical company with a large vaccines business, including shingles, meningitis, RSV and pediatric vaccines.
BIKEN
biken.or.jp Large pharma Japanese vaccine maker linked to Osaka University, producing influenza and other vaccines.	Booth Exhibiting at Booth 349
HIPRA Amer, Spain
hipra.com Large pharma Spanish maker of human and animal vaccines, including a COVID-19 vaccine.	Booth Exhibiting at Booth 540